Effectiveness of Pelvic Floor Muscle and Abdominal Training in Women With Stress Urinary Incontinence

Sponsor
Trakya University (Other)
Overall Status
Completed
CT.gov ID
NCT03401983
Collaborator
(none)
64
2
6.9

Study Details

Study Description

Brief Summary

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence.

This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT "Pelvic Floor Muscle Training" and 32 PFMT+AT "Abdominal Training") by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks.

Condition or Disease Intervention/Treatment Phase
  • Other: Pelvic Floor Muscle Training and Abdominal Training
  • Other: Pelvic Floor Muscle Training
N/A

Detailed Description

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence.

This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT "Pelvic Floor Muscle Training" and 32 PFMT+AT "Abdominal Training") by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks.

Participation of 29 patients from each group in the study was determined as sufficient to test the two-way hypothesis, with an effect size of 0.75, with an alpha level of 0.05, and with a power of 80%. However, 32 patients from each group were included as a precaution against possible missing data.

These women were randomly divided into the PFMT+AT (n=32) and PFMT (n=32) groups using a computer based randomization scheme. The data were collected from both groups at the 0th, 4th, and 8th weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effectiveness of Pelvic Floor Muscle and Abdominal Training in Women With Stress Urinary Incontinence: A Randomized Controlled Study
Actual Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Mar 31, 2017
Actual Study Completion Date :
Mar 31, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: PFMT + AT

Pelvic Floor Muscle Training and Abdominal Training

Other: Pelvic Floor Muscle Training and Abdominal Training
Pelvic Floor Muscle Training + Abdominal Training program was used in the study. The follow-up measurements of the PFMT+AT group were obtained in the 0th, 4th, and 8th weeks.

Active Comparator: PFMT

Pelvic Floor Muscle Training

Other: Pelvic Floor Muscle Training
Pelvic Floor Muscle Training program was used in the study. The follow-up measurements of the PFMT group were obtained in the 0th, 4th, and 8th weeks.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline pelvic floor muscle strength at 8 weeks [0th, 4th, and 8th weeks.]

    Pelvic floor muscle strength was measured using a perineometry device

Secondary Outcome Measures

  1. Change from baseline UDI-6 score at 8 weeks [0th, 4th, and 8th weeks.]

    Urinary symptoms were measured using the Urinary Distress Inventory (UDI-6)

  2. Change from baseline IIQ-7 score at 8 weeks [0th, 4th, and 8th weeks]

    Urinary symptoms were measured using the Incontinence Impact Questionnaire (IIQ-7),

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • 18-49 years

  • Meet the diagnosis of simple female stress urinary incontinence (Degree 0 or 1)

  • Volunteer to participate the study

Exclusion Criteria

  • BMI ≥30

  • Hysterectomy, urinary incontinence or pelvic floor operations

  • Chronic health problem (cardiovascular, cerebral, diabetes, liver, kidney, psychiatric disease, etc.)

  • Urge urinary incontinence, mixed urinary incontinence, overflow urinary incontinence

  • SUI Degree ≥2

  • Symptomatic urinary tract infection

  • During pregnancy or lactation period

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Trakya University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hatice Kahyaoglu Sut, Head of Department of Obstetrics and Gynecology Nursing, Trakya University
ClinicalTrials.gov Identifier:
NCT03401983
Other Study ID Numbers:
  • Effectiveness of Pelvic Floor
First Posted:
Jan 17, 2018
Last Update Posted:
Jan 17, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Hatice Kahyaoglu Sut, Head of Department of Obstetrics and Gynecology Nursing, Trakya University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 17, 2018